Search Results - "Pinheiro, Geraldo R"
-
1
Perceptions of the population regarding generic drugs in Brazil: a nationwide survey
Published in BMC public health (10-02-2015)“…Generic drugs (GDs) offer a way to reduce health spending without sacrificing quality. Despite this, there are doubts as to their acceptance by the population…”
Get full text
Journal Article -
2
Decreasing delays in the diagnosis and treatment of rheumatoid arthritis in Brazil: a nationwide multicenter observational study
Published in Advances in rheumatology (London, England) (06-02-2023)“…Management delays imply worse outcomes in rheumatoid arthritis (RA) and, therefore, should be minimized. We evaluated changes in diagnostic and treatment…”
Get full text
Journal Article -
3
International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group
Published in Arthritis care & research (2010) (01-12-2019)“…Objective The implementation of value‐based health care in inflammatory arthritis requires a standardized set of modifiable outcomes and risk‐adjustment…”
Get full text
Journal Article -
4
The Long Pentraxin 3 Contributes to Joint Inflammation in Gout by Facilitating the Phagocytosis of Monosodium Urate Crystals
Published in The Journal of immunology (1950) (15-03-2019)“…The purpose of this study was to investigate the role of pentraxin 3 (PTX3), a pivotal component of the innate immune system, in gout. Levels of PTX3 and IL-1β…”
Get full text
Journal Article -
5
High Levels of Polypharmacy in Rheumatoid Arthritis—A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study
Published in Journal of pharmacy practice (01-06-2021)“…Background: Rheumatoid arthritis (RA) is associated with high frequency of comorbidities and increased risk of polypharmacy. Although there is a great…”
Get full text
Journal Article -
6
Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs—Data From the Brazilian Registry for Biologics Monitoring
Published in Journal of clinical rheumatology (01-03-2020)“…BACKGROUNDThe safety profile of biologic drugs might present substantial regional differences. Since 2009, the Brazilian Society of Rheumatology has maintained…”
Get full text
Journal Article -
7
Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring
Published in Journal of clinical rheumatology (01-03-2020)“…The safety profile of biologic drugs might present substantial regional differences. Since 2009, the Brazilian Society of Rheumatology has maintained…”
Get full text
Journal Article -
8
Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
Published in Clinical rheumatology (01-10-2019)“…The original version of this article, unfortunately, contained an error. The first and family name of Loreto Massardo was interchanged and is now presented…”
Get full text
Journal Article -
9
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis
Published in Rheumatology (Oxford, England) (01-02-2024)“…To test the association of use of antimalarials with the overall safety of treatment in RA patients receiving one or multiple courses of biologic (b)DMARDs or…”
Get full text
Journal Article -
10
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil)
Published in Journal of rheumatology (01-10-2021)“…To evaluate the safety of the methotrexate (MTX)-leflunomide (LEF) combination in rheumatoid arthritis (RA), comparing it with other therapeutic schemes…”
Get full text
Journal Article -
11
Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL
Published in Clinical rheumatology (01-05-2015)“…Treatment survival with biological therapy may be influenced by many factors, and it seems to be different among various rheumatic diseases and biological…”
Get full text
Journal Article -
12
Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
Published in Clinical rheumatology (01-10-2019)“…Objectives To identify baseline predictors of remission and low disease activity (LDA) in early rheumatoid arthritis (RA) from the GLADAR ( Grupo Latino…”
Get full text
Journal Article -
13
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey
Published in Clinical rheumatology (01-03-2017)“…The age of onset of rheumatoid arthritis (RA) is an important outcome predictor. Northern countries report an age of RA onset of around 50 years, but…”
Get full text
Journal Article